Related Experiment Videos
DNA cancer vaccines: a gene gun approach
D M Mahvi1, M J Sheehy, N S Yang
1Department of Surgery, University of Wisconsin School of Medicine, Madison, USA.
Abstract:
A wide variety of approaches, all using gene transfer, have been tested experimentally as alternative means to vaccinate against cancer, either prophylactically or therapeutically. These include both ex vivo and in vivo gene transfer to tumour and/or non-tumour cells, using both viral and non-viral vectors. The transferred DNA has varied widely as well, including genomic or cDNA encoding tumour-associated or oncofoetal antigens, cytokines, histocompatibility molecules, and costimulatory molecules. Several of these approaches have been applied in human clinical trials. This review summarizes those approaches, then compares and evaluates various methods using cytokine DNA in conjunction with autologous tumour cells, with particular emphasis on particle-mediated gene transfer via a gene gun. Finally, prospects and needs for further development are discussed.
Insights
Gene transfer methods offer novel cancer vaccination strategies, utilizing various vectors and DNA payloads. Particle-mediated gene transfer, particularly with cytokine DNA, shows promise for therapeutic cancer vaccines.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Gene transfer techniques are explored for cancer vaccination, both preventative and therapeutic.
- Approaches involve ex vivo and in vivo gene transfer using viral and non-viral vectors.
- Transferred genetic material includes genes for tumor antigens, cytokines, and costimulatory molecules.
Purpose of the Study:
- To review and evaluate gene transfer-based cancer vaccination strategies.
- To compare methods using cytokine DNA with autologous tumor cells.
- To highlight particle-mediated gene transfer (gene gun) for cancer immunotherapy.
Main Methods:
- Review of experimental and clinical studies on gene transfer for cancer vaccines.
- Comparison of different gene transfer vectors (viral and non-viral).
- Evaluation of DNA payloads, including cytokines and tumor antigens.
- Specific focus on particle-mediated gene transfer (gene gun) technology.
Main Results:
- Multiple gene transfer approaches have been investigated for cancer vaccination.
- Several strategies have progressed to human clinical trials.
- Cytokine gene transfer combined with autologous tumor cells shows therapeutic potential.
Conclusions:
- Gene transfer represents a versatile platform for developing cancer vaccines.
- Particle-mediated gene transfer offers a promising method for delivering therapeutic genes.
- Further research is needed to optimize gene transfer strategies for effective cancer immunotherapy.